Tokyo Tape
Sign in
← Kirin Holdings

Half-year report · Q2

2503.TEDINET S100U68G
Period2024-01-01 → 2024-06-30
Filed2024-08-08
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥1.10T2024-01-01 → 2024-06-30Cons.Revenue IFRS
Revenue¥2.13T2023-01-01 → 2023-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥970.2bn2023-01-01 → 2023-06-30Cons.Revenue IFRS
Operating income¥80.9bn2024-01-01 → 2024-06-30Cons.Operating profit loss IFRS
Operating income¥36.9bn2023-01-01 → 2023-06-30Cons.Operating profit loss IFRS
Profit before tax¥108.5bn2024-01-01 → 2024-06-30Cons.Profit loss before tax IFRS
Profit before tax¥197.0bn2023-01-01 → 2023-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥57.1bn2023-01-01 → 2023-06-30Cons.Profit loss before tax IFRS
Net income (owners)¥57.2bn2024-01-01 → 2024-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥112.7bn2023-01-01 → 2023-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥32.0bn2023-01-01 → 2023-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income¥74.2bn2024-01-01 → 2024-06-30Cons.Profit loss IFRS
Net income¥41.8bn2023-01-01 → 2023-06-30Cons.Profit loss IFRS
Total assets¥3.13Tat 2024-06-30Cons.Assets IFRS
Total assets¥2.87Tat 2023-12-31Cons.Assets IFRS
Total assets¥2.60Tat 2023-06-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥1.55Tat 2024-06-30Cons.Liabilities IFRS
Total liabilities¥1.44Tat 2023-12-31Cons.Liabilities IFRS
Net assets / equity¥1.59Tat 2024-06-30Cons.Equity IFRS
Net assets / equity¥1.43Tat 2023-12-31Cons.Equity IFRS
Net assets / equity¥1.33Tat 2023-06-30Cons.Equity IFRS
Net assets / equity¥1.25Tat 2022-12-31dCons.Equity IFRS
Equity (owners)¥1.29Tat 2024-06-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.13Tat 2023-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.06Tat 2023-06-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥138.4bnat 2024-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥131.4bnat 2023-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥140.0bnat 2023-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥88.1bnat 2022-12-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥108.7bn2024-01-01 → 2024-06-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥203.2bn2023-01-01 → 2023-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥58.9bn2023-01-01 → 2023-06-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥116.0bn2024-01-01 → 2024-06-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥226.1bn2023-01-01 → 2023-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥56.0bn2023-01-01 → 2023-06-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥21.6bn2024-01-01 → 2024-06-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥35.9bn2023-01-01 → 2023-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow¥15.6bn2023-01-01 → 2023-06-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥70.652024-01-01 → 2024-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥139.162023-01-01 → 2023-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥39.52023-01-01 → 2023-06-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥70.652024-01-01 → 2024-06-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥139.152023-01-01 → 2023-12-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥39.492023-01-01 → 2023-06-30Cons.Diluted earnings loss per share IFRS
Equity ratio41.2%at 2024-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio39.5%at 2023-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio40.8%at 2023-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 46
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2024-01-01 → 2024-06-30¥45.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2024-01-01 → 2024-06-30¥10.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2024-01-01 → 2024-06-30¥34.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-01-01 → 2024-06-30−¥331m
Reconciling Itemsreconcilingrevenue2024-01-01 → 2024-06-30−¥38.5bn
Reconciling Itemsreconcilingrevenue intersegment2024-01-01 → 2024-06-30−¥38.5bn
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-06-30−¥26.5bn
jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segmentrevenue2024-01-01 → 2024-06-30¥513.7bn
jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segmentrevenue external2024-01-01 → 2024-06-30¥512.5bn
jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segmentrevenue intersegment2024-01-01 → 2024-06-30¥1.2bn
jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segmentsegment profit2024-01-01 → 2024-06-30¥50.3bn
jpcrp040300-q2r_E00395-000Health Sciencereportable segmentrevenue2024-01-01 → 2024-06-30¥71.1bn
jpcrp040300-q2r_E00395-000Health Sciencereportable segmentrevenue external2024-01-01 → 2024-06-30¥69.6bn
jpcrp040300-q2r_E00395-000Health Sciencereportable segmentrevenue intersegment2024-01-01 → 2024-06-30¥1.6bn
jpcrp040300-q2r_E00395-000Health Sciencereportable segmentsegment profit2024-01-01 → 2024-06-30−¥1.6bn
jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segmentrevenue2024-01-01 → 2024-06-30¥271.5bn
jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segmentrevenue external2024-01-01 → 2024-06-30¥270.0bn
jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segmentrevenue intersegment2024-01-01 → 2024-06-30¥1.5bn
jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segmentsegment profit2024-01-01 → 2024-06-30¥30.1bn
jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segmentrevenue2024-01-01 → 2024-06-30¥233.0bn
jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segmentrevenue external2024-01-01 → 2024-06-30¥232.8bn
jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segmentrevenue intersegment2024-01-01 → 2024-06-30¥132m
jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segmentsegment profit2024-01-01 → 2024-06-30¥41.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-01-01 → 2023-06-30¥44.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-01-01 → 2023-06-30¥13.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-01-01 → 2023-06-30¥31.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-01-01 → 2023-06-30−¥435m
Reconciling Itemsreconcilingrevenue2023-01-01 → 2023-06-30−¥36.1bn
Reconciling Itemsreconcilingrevenue intersegment2023-01-01 → 2023-06-30−¥36.1bn
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-06-30−¥24.0bn
jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segmentrevenue2023-01-01 → 2023-06-30¥482.0bn
jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segmentrevenue external2023-01-01 → 2023-06-30¥480.9bn
jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segmentrevenue intersegment2023-01-01 → 2023-06-30¥1.0bn
jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segmentsegment profit2023-01-01 → 2023-06-30¥45.0bn
jpcrp040300-q2r_E00395-000Health Sciencereportable segmentrevenue2023-01-01 → 2023-06-30¥38.0bn
jpcrp040300-q2r_E00395-000Health Sciencereportable segmentrevenue external2023-01-01 → 2023-06-30¥36.2bn
jpcrp040300-q2r_E00395-000Health Sciencereportable segmentrevenue intersegment2023-01-01 → 2023-06-30¥1.8bn
jpcrp040300-q2r_E00395-000Health Sciencereportable segmentsegment profit2023-01-01 → 2023-06-30−¥4.4bn
jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segmentrevenue2023-01-01 → 2023-06-30¥242.4bn
jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segmentrevenue external2023-01-01 → 2023-06-30¥241.0bn
jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segmentrevenue intersegment2023-01-01 → 2023-06-30¥1.4bn
jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segmentsegment profit2023-01-01 → 2023-06-30¥23.0bn
jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segmentrevenue2023-01-01 → 2023-06-30¥199.2bn
jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segmentrevenue external2023-01-01 → 2023-06-30¥199.0bn
jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segmentrevenue intersegment2023-01-01 → 2023-06-30¥210m
jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segmentsegment profit2023-01-01 → 2023-06-30¥36.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 831
ItemContextValueUnit
Profit loss IFRSCurrentYTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember－JPY
Other comprehensive income IFRSCurrentYTDDuration_ShareCapitalIFRSMember－JPY
Other comprehensive income IFRSCurrentYTDDuration_CapitalSurplusIFRSMember－JPY
Other comprehensive income IFRSCurrentYTDDuration_RetainedEarningsIFRSMember－JPY
Other comprehensive income IFRSCurrentYTDDuration_TreasurySharesIFRSMember－JPY
Other comprehensive income IFRSCurrentYTDDuration_NetChangeInFairValueOfEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember2132000000JPY
Other comprehensive income IFRSCurrentYTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember-621000000JPY
Comprehensive income IFRSCurrentYTDDuration_ShareCapitalIFRSMember－JPY
Comprehensive income IFRSCurrentYTDDuration_CapitalSurplusIFRSMember－JPY
Comprehensive income IFRSCurrentYTDDuration_RetainedEarningsIFRSMember57220000000JPY
Comprehensive income IFRSCurrentYTDDuration_TreasurySharesIFRSMember－JPY
Comprehensive income IFRSCurrentYTDDuration_NetChangeInFairValueOfEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember2132000000JPY
Comprehensive income IFRSCurrentYTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember-621000000JPY
Dividends ss IFRSCurrentYTDDuration_ShareCapitalIFRSMember－JPY
Dividends ss IFRSCurrentYTDDuration_CapitalSurplusIFRSMember－JPY
Dividends ss IFRSCurrentYTDDuration_RetainedEarningsIFRSMember-29560000000JPY
Dividends ss IFRSCurrentYTDDuration_TreasurySharesIFRSMember－JPY
Dividends ss IFRSCurrentYTDDuration_NetChangeInFairValueOfEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember－JPY
Dividends ss IFRSCurrentYTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember－JPY
Purchase of treasury shares ss IFRSCurrentYTDDuration_ShareCapitalIFRSMember－JPY
Purchase of treasury shares ss IFRSCurrentYTDDuration_CapitalSurplusIFRSMember－JPY
Purchase of treasury shares ss IFRSCurrentYTDDuration_RetainedEarningsIFRSMember－JPY
Purchase of treasury shares ss IFRSCurrentYTDDuration_TreasurySharesIFRSMember-14000000JPY
Purchase of treasury shares ss IFRSCurrentYTDDuration_NetChangeInFairValueOfEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember－JPY
Purchase of treasury shares ss IFRSCurrentYTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember－JPY
Disposal of treasury shares ss IFRSCurrentYTDDuration_ShareCapitalIFRSMember－JPY
Disposal of treasury shares ss IFRSCurrentYTDDuration_CapitalSurplusIFRSMember-0JPY
Disposal of treasury shares ss IFRSCurrentYTDDuration_RetainedEarningsIFRSMember－JPY
Disposal of treasury shares ss IFRSCurrentYTDDuration_TreasurySharesIFRSMember1000000JPY
Disposal of treasury shares ss IFRSCurrentYTDDuration_NetChangeInFairValueOfEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember－JPY
Disposal of treasury shares ss IFRSCurrentYTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember－JPY
Change in scope of consolidation ss IFRSCurrentYTDDuration_ShareCapitalIFRSMember－JPY
Change in scope of consolidation ss IFRSCurrentYTDDuration_CapitalSurplusIFRSMember－JPY
Change in scope of consolidation ss IFRSCurrentYTDDuration_RetainedEarningsIFRSMember－JPY
Change in scope of consolidation ss IFRSCurrentYTDDuration_TreasurySharesIFRSMember－JPY
Change in scope of consolidation ss IFRSCurrentYTDDuration_NetChangeInFairValueOfEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember－JPY
Change in scope of consolidation ss IFRSCurrentYTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember－JPY
Share based payment transactions ss IFRSCurrentYTDDuration_ShareCapitalIFRSMember－JPY
Share based payment transactions ss IFRSCurrentYTDDuration_CapitalSurplusIFRSMember-141000000JPY
Share based payment transactions ss IFRSCurrentYTDDuration_RetainedEarningsIFRSMember-11000000JPY
Share based payment transactions ss IFRSCurrentYTDDuration_TreasurySharesIFRSMember361000000JPY
Share based payment transactions ss IFRSCurrentYTDDuration_NetChangeInFairValueOfEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember－JPY
Share based payment transactions ss IFRSCurrentYTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember－JPY
Changes in ownership interests in subsidiaries that do not result in loss of control ss IFRSCurrentYTDDuration_ShareCapitalIFRSMember－JPY
Changes in ownership interests in subsidiaries that do not result in loss of control ss IFRSCurrentYTDDuration_CapitalSurplusIFRSMember-7742000000JPY
Changes in ownership interests in subsidiaries that do not result in loss of control ss IFRSCurrentYTDDuration_RetainedEarningsIFRSMember－JPY
Changes in ownership interests in subsidiaries that do not result in loss of control ss IFRSCurrentYTDDuration_TreasurySharesIFRSMember－JPY
Changes in ownership interests in subsidiaries that do not result in loss of control ss IFRSCurrentYTDDuration_NetChangeInFairValueOfEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember－JPY
Changes in ownership interests in subsidiaries that do not result in loss of control ss IFRSCurrentYTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember－JPY
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration_ShareCapitalIFRSMember－JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-12-31pass
balance sheet identityconsolidated 2024-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2024-01-01/2024-06-30pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-06-30pass
statement vs summary · operating cash flowconsolidated 2024-01-01/2024-06-30pass
statement vs summary · revenueconsolidated 2023-01-01/2023-06-30pass
statement vs summary · revenueconsolidated 2024-01-01/2024-06-30pass
statement vs summary · total assetsconsolidated 2023-12-31pass
statement vs summary · total assetsconsolidated 2024-06-30pass